The German pharmaceutical company Medac, in August, will begin Phase 3 of a clinical trial to access the therapeutic potential of terguride,…
Articles by Magdalena Kegel
Japanese scientists have discovered that endothelin-1 (ET-1) signaling through its B-type receptor contributes to the development of skin fibrosis. The…
Clopidogrel (Plavix) treatment may worsen blood vessel dysfunction and lead to the development of new digital ulcers in patients with…
Immune T-cells induced by the autoantigen topoisomerase-I were linked to lung fibrosis and found to predict disease progression in scleroderma patients.
Edward Harris, the man behind the Scleroderma Education Project, recently presented a review and analysis of published data about…
Scleroderma patients with worsening interstitial lung disease would likely benefit from a treatment regimen consisting of cyclophosphamide pulses, followed by maintenance…
Antegrin Therapeutics announced that it has acquired the licenses to a series of drugs targeting integrins. With the addition of…
Bosentan and other drugs belonging to the group of endothelin-1 receptor blockers showed promise in preclinical fibrosis models, but delivered…
A research team has developed a cannabinoid-based drug that stimulates not only one, but two, receptors believed to be involved…
The European Scleroderma Trials and Research group (EUSTAR) and the World Scleroderma Foundation recently announced the launch of a…